0001209191-19-025413.txt : 20190419 0001209191-19-025413.hdr.sgml : 20190419 20190419213840 ACCESSION NUMBER: 0001209191-19-025413 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190125 FILED AS OF DATE: 20190419 DATE AS OF CHANGE: 20190419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nance Mark E CENTRAL INDEX KEY: 0001755882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 19758444 MAIL ADDRESS: STREET 1: 1333 S SPECTRUM BLVD #100 CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-25 0 0001516479 Insys Therapeutics, Inc. INSY 0001755882 Nance Mark E 1333 S SPECTRUM BLVD #100 CHANDLER AZ 85286 0 1 0 0 Chief Legal Officer & Gen Cnsl Common Stock 2019-01-25 4 A 0 10000 0.00 A 25000 D Employee Stock Option (right to buy) 3.81 2019-01-25 4 A 0 70000 0.00 A 2029-01-24 Common Stock 70000 70000 D The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023. /s/ Mark E. Nance 2019-04-19